Results 131 to 140 of about 19,480 (219)

Multiorgan repair by MSC-derived extracellular vesicles in hepatorenal syndrome through necroptosis alleviation, immune reprogramming and fibrosis resolution. [PDF]

Extracell Vesicles Circ Nucl Acids
Zhang KC, Mu SH, Song RF, Gao YR, Zhang S, Zheng CX, Jin Y, Gong Z, Sui BD, Zhang M.   +9 more
europepmc   +1 more source

Early Diagnosis and Timely Terlipressin in Hepatorenal Syndrome Improves Projected Outcomes and Lowers Cost. [PDF]

Clinicoecon Outcomes Res
Gallegos-Orozco JF, O'Leary JG, Reddy KG, Bindra J, Chopra I, Niewoehner J, Huang X.   +6 more
europepmc   +1 more source

Cefotaxime desensitization [PDF]

, 1993
Bogner, Johannes R., Hehlmann, R., Hofmeister, F., Papakonstantino, G.   +3 more
core   +1 more source

Real-World Use of Terlipressin in Cirrhosis and Acute Kidney Injury: Frequent Use Beyond Hepatorenal Syndrome. [PDF]

Clin Gastroenterol Hepatol
Ma AT, Juanola A, Patidar KR, Barone A, Incicco S, Kulkarni AV, Verma N, Lange CM, Xie Q, Alessandria C, Cerda Reyes E, Maiwall R, Kim JH, Marciano S, Farias AQ, Toledo C, Nardelli S, Vorobioff JD, Roblero JP, Thévenot T, Papp M, Maan R, Solé C, Cordova-Gallardo J, Simonetto DA, Fouad Y, Balcar L, Raevens S, Nabilou P, Caraceni P, Merli M, Presa J, Laleman W, Krag A, Bruns T, Pereira G, Mattos AZ, Arab JP, Wentworth B, Abdelkader NA, Wong YJ, Kim SE, Roux O, Takkenberg RB, Galante A, Goncalves LL, Pyrsopoulos NT, Pérez Hernández JL, Asrani SK, Torre A, Díaz-Ferrer J, Orman ES, Perricone G, Gadano A, Ivashkin V, Fassio E, Marino M, Vargas V, Rabinowich L, Montes P, Mohammed A, Carrera E, Cabrera MC, Girala M, Samant H, Madaleno J, Kim WR, Ferreira CN, Allegretti AS, Sarin SK, Ginès P, Angeli P, Solà E, Piano S, International Club of Ascites GLOBAL AKI team.   +74 more
europepmc   +1 more source

Challenges in the Treatment of Hepatorenal Syndrome-Acute Kidney Injury: A US Chart Review of Treatment Patterns and Survival Outcomes. [PDF]

JGH Open
Sanyal AJ, Reddy KR, Brown KA, Landis CS, Cullaro G, Huang X, Kelkar SS, Raina R, Corman S, Kebede N, Edmundson P, Jamil K, Allegretti AS.   +12 more
europepmc   +1 more source

Predictors of response to terlipressin therapy in hepatorenal syndrome: Metabolomic and proteomic analysis from the CONFIRM trial. [PDF]

Hepatol Commun
Allegretti AS, Levitsky J, Sharma P, Ouyang T, Jamil K, Silvey S, Bajaj JS.   +6 more
europepmc   +1 more source

Mixed lymphocyte culture and graft rejection. [PDF]

, 1973
Bethell, D, Corman, J, Fiala, JM, Ishikawa, M, Iwatsuki, S, Johansen, TS, Kashiwagi, N, Starzl, TE   +7 more
core  

A new multisystem ERCC1-hepatorenal syndrome: insights from a clinical cohort, molecular pathogenesis, and management guidelines. [PDF]

Eur J Hum Genet
White SM, Wondergem AP, Breet I, Dittmaier M, Bell K, Richmond CM, Hardikar W, Bhatia K, Quinlan C, Orchard D, D'Souza A, Chazin WJ, Smith C, Sparkes R, Lam S, Carter A, Hopkin RJ, Khendek L, Sullivan BR, Becher N, Simonsen AKW, Kvistgaard H, Dempsey K, Miethke AG, Gregersen PA, Phillips E, Luijsterburg MS.   +26 more
europepmc   +1 more source

Mapping the hemodynamic effects of terlipressin in patients with hepatorenal syndrome using advanced magnetic resonance imaging. [PDF]

JHEP Rep
Danielsen KV, Hove JD, Nabilou P, Kronborg TM, Wiese S, Siebner HR, Scott R, Francis ST, Aithal GP, Møller S, Bendtsen F.   +10 more
europepmc   +1 more source

Hepatorenal syndrome: Paving a pathway from a fatal condition to an opportunity to preserve kidney function. [PDF]

World J Nephrol
Gonzalez FM.
europepmc   +1 more source